Opinion Split Over ICH Proposal To Limit Safety Data Collection
Some Feel ICH Guide Can Jeopardize Data Collection
Executive Summary
A draft international guideline that proposes limiting safety data collection in premarket and postmarket trials if the drug’s safety profile is sufficiently characterized has drawn a varied response from a range of stakeholders in the EU.